DEKRA accredited under the MDR

Europe – MDCG 2022-4 Rev.1 Guidance on appropriate surveillance regarding the transitional provisions under...

Article 120(2) and 120(3) of the Medical Device Regulation (EU) 2017/745 (MDR) state that devices which are covered by valid certificates issued by a notified...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2022-21 Guidance on periodic safety update report (PSUR) according to regulation...

The Periodic Safety Update Report (PSUR) has been introduced in Article 86 of the Medical Device Regulation (MDR) 2017/745. The introduction of the PSUR requirement...

Europe – MDCG 2022-19 Performance study application/notification documents under Regulation (EU) 2017/746

The sponsor of a performance study is required to submit an application/notification1 to the Member State(s) in which a performance study is to be...
Norway’s DNV GL Designated as 10th Notified Body Under MDRClinical Trials With Conditions

Europe – EU issues implementing regs for devices without an intended medical purpose

Regulation (EU) 2017/745 lays down rules concerning the placing on the market, making available on the market or putting into service of medical devices...

Europe – MDCG 2022-18 : Position Paper on the application of Article 97 MDR...

In accordance with Article 5 of Regulation (EU) 2017/745 on medical devices (MDR), a device may be placed on the market only if it complies...
Joint Implementation/preparedness plan on the new Medical Devices Regulation 2017/745 (MDR) on March 11th, 2020

Europe – European Council members support proposal to delay MDR deadlines

European Council members expressed support for a proposal by the European Commission to delay the transitional deadlines for medical devices under the Medical Devices...

Europe – MDCG 2022-17 – MDCG position paper on ‘hybrid audits’

This paper outlines the Medical Device Coordination Group (MDCG) position on the possible use of hybrid audits by notified bodies under Regulation (EU) 2017/745...
Double peine pour la medtech suisse

USA – Switzerland eyes allowing FDA-approved medical devices onto its market

The Swiss parliament has asked the country’s Federal Council to adapt its laws to allow medical devices that have been vetted by non-European regulators,...

Europe – Artificial Intelligence Act : un nouveau règlement européen à suivre de près

L’AIA est une proposition de règlement du parlement et du conseil européens dévoilée le 21 avril 2021, dont l'entrée en vigueur est programmée dans...
Advice for Management of Clinical trials in relation to Coronavirus

UK – Borderline products: how to tell if your product is a medical device...

Some products are hard to distinguish from a medical device, for example products that might be medicines, cosmetics, food supplements, biocidal products or personal...

NOS PROCHAINES FORMATIONS